Devereux T R, Anderson M W, Belinsky S A
Laboratory of Molecular Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709.
Carcinogenesis. 1991 Feb;12(2):299-303. doi: 10.1093/carcin/12.2.299.
The role of ras activation in the formation of spontaneous and chemically induced tumors was evaluated in the C3H mouse, a strain that has a low incidence of spontaneous lung tumors. Lung tumors were induced in C3H mice by treatment with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 50 mg/kg, or nitrosodimethylamine (NDMA), 3 mg/kg for 7 weeks (3 times/week, i.p.). Eleven tumors from each treatment group were evaluated for activated ras genes by direct sequencing and oligonucleotide hybridization to slot blots of amplified DNA from these tumors. An activated K-ras gene was detected in 100% of NDMA- and NNK-induced lung tumors, and the activating mutation detected in all samples was a GC to AT transition (GGT to GAT) in codon 12. In contrast, only 40% of the seven spontaneous lung tumors analyzed contained an activated K-ras gene and the mutations identified were not localized to either a specific base or codon. Both NNK and NDMA can be activated via alpha-hydroxylation to methylating agents. The GC to AT mutation observed in codon 12 in the nitrosamine-induced tumors is consistent with the formation of an O6-methylguanine (O6MG) adduct. Similar concentrations (13-15 pmoles/mumol deoxyguanosine) of this promutagenic adduct were detected in lungs during treatment with either NNK or NDMA. Thus, both these nitrosamines appear to activate the K-ras gene in lung through a direct genotoxic mechanism involving the formation of the O6MG adduct. The frequency of K-ras activation was similar in chemically induced lung tumors from the sensitive A/J strain and the C3H mouse, indicating that susceptibility for neoplasia in these stains is not related to the ability to activate this gene. Although tumors were induced in lung from 100% of C3H mice following chronic carcinogen exposure, both the size and the multiplicity was significantly less, while latency was longer than that observed in the A/J mouse. These differences could not be attributed to an altered propensity for DNA damage, but rather suggest that genetic loci which regulate clonal expansion and growth of initiated cells play a major role in the susceptibility of pulmonary neoplasia.
在自发肺肿瘤发病率较低的C3H小鼠中,评估了ras激活在自发肿瘤和化学诱导肿瘤形成中的作用。通过腹腔注射给予C3H小鼠50mg/kg的4-(N-甲基-N-亚硝基氨基)-1-(3-吡啶基)-1-丁酮(NNK)或3mg/kg的亚硝基二甲胺(NDMA),每周3次,持续7周,诱导肺肿瘤。通过直接测序和与这些肿瘤扩增DNA的狭缝印迹进行寡核苷酸杂交,对每个治疗组的11个肿瘤进行激活的ras基因评估。在100%的NDMA和NNK诱导的肺肿瘤中检测到激活的K-ras基因,并且在所有样本中检测到的激活突变是密码子12中的GC到AT转换(GGT到GAT)。相比之下,在分析的7个自发肺肿瘤中,只有40%含有激活的K-ras基因,并且鉴定出的突变并不局限于特定的碱基或密码子。NNK和NDMA都可以通过α-羟基化激活为甲基化剂。在亚硝胺诱导的肿瘤中,密码子12中观察到的GC到AT突变与O6-甲基鸟嘌呤(O6MG)加合物的形成一致。在用NNK或NDMA治疗期间,在肺中检测到相似浓度(13-15pmol/μmol脱氧鸟苷)的这种促突变加合物。因此,这两种亚硝胺似乎都通过涉及O6MG加合物形成的直接遗传毒性机制激活肺中的K-ras基因。在敏感的A/J品系和C3H小鼠的化学诱导肺肿瘤中,K-ras激活的频率相似,表明这些品系中肿瘤形成的易感性与激活该基因的能力无关。尽管在慢性致癌物暴露后,100%的C3H小鼠肺部都诱导出了肿瘤,但肿瘤的大小和数量都明显较少,而潜伏期比A/J小鼠更长。这些差异不能归因于DNA损伤倾向的改变,而是表明调节起始细胞克隆扩增和生长的基因座在肺肿瘤易感性中起主要作用。